{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:36:35Z","timestamp":1790192195874,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81920108033"],"award-info":[{"award-number":["81920108033"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074011"],"award-info":[{"award-number":["82074011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82122074"],"award-info":[{"award-number":["82122074"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130115"],"award-info":[{"award-number":["82130115"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ejphar.2023.176196","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T17:52:43Z","timestamp":1700761963000},"page":"176196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Lusianthridin ameliorates high fat diet-induced metabolic dysfunction-associated fatty liver disease via activation of FXR signaling pathway."],"prefix":"10.1016","volume":"965","author":[{"given":"Xiaowen","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linshan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aizhen","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6528-4652","authenticated-orcid":false,"given":"Rufeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2797-4625","authenticated-orcid":false,"given":"Zhengtao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4831-3300","authenticated-orcid":false,"given":"Lili","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2023.176196_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152932","article-title":"Lusianthridin targeting of lung cancer stem cells via Src-STAT3 suppression","volume":"62","author":"Bhummaphan","year":"2019","journal-title":"Phytomedicine"},{"issue":"5","key":"10.1016\/j.ejphar.2023.176196_bib2","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.jcmgh.2021.01.012","article-title":"Transcriptional Regulation of metabolic pathways via lipid-sensing nuclear receptors PPARs, FXR, and LXR in NASH","volume":"11","author":"Cariello","year":"2021","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.ejphar.2023.176196_bib3","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile acid control of metabolism and inflammation in obesity, type 2 Diabetes, dyslipidemia, and non-alcoholic fatty liver disease","volume":"152","author":"Ch\u00e1vez-Talavera","year":"2017","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.ejphar.2023.176196_bib4","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/MEG.0000000000002497","article-title":"Validation of non-alcoholic fatty liver disease (NAFLD) related steatosis indices in metabolic associated fatty liver disease (MAFLD) and comparison of the diagnostic accuracy between NAFLD and MAFLD","volume":"35","author":"Chen","year":"2023","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.ejphar.2023.176196_bib5","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cmet.2021.06.012","article-title":"FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption","volume":"33","author":"Clifford","year":"2021","journal-title":"Cell Metabol."},{"issue":"5","key":"10.1016\/j.ejphar.2023.176196_bib6","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00125-013-2869-1","article-title":"Insulin signalling mechanisms for triacylglycerol storage","volume":"56","author":"Czech","year":"2013","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.ejphar.2023.176196_bib7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.ejphar.2023.176196_bib8","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jhep.2021.10.016","article-title":"Exposure to air pollution is associated with an increased risk of metabolic dysfunction-associated fatty liver disease","volume":"76","author":"Guo","year":"2022","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.ejphar.2023.176196_bib9","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.ejphar.2023.176196_bib10","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","article-title":"The cellular thermal shift assay for evaluating drug target interactions in cells","volume":"9","author":"Jafari","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejphar.2023.176196_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113836","article-title":"Pharmacokinetic, bioavailability, and metabolism studies of lusianthridin, a dihydrophenanthrene compound, in rats by liquid chromatography\/electrospray ionization tandem mass spectrometry","volume":"195","author":"Ju","year":"2021","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ejphar.2023.176196_bib12","doi-asserted-by":"crossref","DOI":"10.1177\/20420188221139650","article-title":"Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with non-alcoholic fatty liver disease","volume":"13","author":"Kaya","year":"2022","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2023.176196_bib13","first-page":"350410","article-title":"Cytotoxic and antimigratory activities of phenolic compounds from dendrobium brymerianum","author":"Klongkumnuankarn","year":"2015","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.ejphar.2023.176196_bib33","doi-asserted-by":"crossref","first-page":"115248","DOI":"10.1016\/j.taap.2020.115248","article-title":"Picroside II alleviates liver injury induced by alpha-naphthylisothiocyanate through AMPK-FXR pathway","volume":"408","author":"Li","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2023.176196_bib32","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1172\/JCI68815","article-title":"Metformin interferes with bile acid homeostasis through AMPK-FXR crosstalk","volume":"124","author":"Lien","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.ejphar.2023.176196_bib14","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s11095-013-0986-7","article-title":"Synthetic FXR agonist GW4064 prevents diet-induced hepatic steatosis and insulin resistance","volume":"30","author":"Ma","year":"2013","journal-title":"Pharmaceut. Res."},{"issue":"2","key":"10.1016\/j.ejphar.2023.176196_bib15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/JOE-13-0109","article-title":"FXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS","volume":"218","author":"Maneschi","year":"2013","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.ejphar.2023.176196_bib16","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1038\/s41467-019-10853-2","article-title":"Molecular tuning of farnesoid X receptor partial agonism","volume":"10","author":"Merk","year":"2019","journal-title":"Nat. Commun."},{"issue":"9972","key":"10.1016\/j.ejphar.2023.176196_bib17","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.ejphar.2023.176196_bib18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/hep.31205","article-title":"Cilofexor, a Non-steroidal FXR agonist, in patients with noncirrhotic NASH: a Phase 2 randomized controlled trial","volume":"72","author":"Patel","year":"2020","journal-title":"hepatology (Baltimore, Md"},{"issue":"5","key":"10.1016\/j.ejphar.2023.176196_bib19","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/oby.22440","article-title":"Bile diversion improves metabolic phenotype dependent on farnesoid X receptor (FXR)","volume":"27","author":"Pierre","year":"2019","journal-title":"Obesity"},{"issue":"5","key":"10.1016\/j.ejphar.2023.176196_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101852","article-title":"Natural (dihydro)phenanthrene plant compounds are direct activators of AMPK through its allosteric drug and metabolite-binding site","volume":"298","author":"Sanders","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.ejphar.2023.176196_bib21","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrendo.2017.91","article-title":"SREBP-regulated lipid metabolism: convergent physiology divergent pathophysiology","volume":"13","author":"Shimano","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"issue":"6","key":"10.1016\/j.ejphar.2023.176196_bib22","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0092-8674(00)00062-3","article-title":"Targeted disruption of the nuclear receptor FXR\/BAR impairs bile acid and lipid homeostasis","volume":"15;102","author":"Sinal","year":"2000","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ejphar.2023.176196_bib23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41575-020-00404-2","article-title":"The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer","volume":"18","author":"Sun","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2023.176196_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1078447","article-title":"Dendrobium officinale alleviates high-fat diet-induced non-alcoholic steatohepatitis by modulating gut microbiota","volume":"13","author":"Tian","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.ejphar.2023.176196_bib25","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/gutjnl-2021-324305","article-title":"Novel therapeutic targets for cholestatic and fatty liver disease","volume":"71","author":"Trauner","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2023.176196_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172661","article-title":"Farnesoid X nuclear receptor agonists for the treatment of non-alcoholic steatohepatitis","volume":"863","author":"Venetsanaki","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.ejphar.2023.176196_bib27","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2023.176196_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.963513","article-title":"Non-alcoholic fatty liver disease-A pilot study investigating early inflammatory and fibrotic biomarkers of NAFLD with alcoholic liver disease","volume":"13","author":"Watt","year":"2022","journal-title":"Front. Physiol."},{"issue":"22","key":"10.1016\/j.ejphar.2023.176196_bib29","doi-asserted-by":"crossref","first-page":"19353","DOI":"10.1074\/jbc.M201584200","article-title":"Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)\/Lep(ob) mice","volume":"277","author":"Yahagi","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.ejphar.2023.176196_bib30","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1021\/np070423f","article-title":"Antifibrotic phenanthrenes of Dendrobium nobile stems","volume":"70","author":"Yang","year":"2007","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejphar.2023.176196_bib34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.biopha.2017.10.153","article-title":"Protective effect of dioscin against thioacetamide-induced acute liver injury via FXR\/AMPK signaling pathway in vivo","volume":"97","author":"Zheng","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.ejphar.2023.176196_bib31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.apsb.2016.07.008","article-title":"Fatty liver diseases, bile acids, and FXR","volume":"6","author":"Zhu","year":"2016","journal-title":"Acta Pharm. Sin. B"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923007100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923007100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:25:37Z","timestamp":1762143937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299923007100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":34,"alternative-id":["S0014299923007100"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.176196","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lusianthridin ameliorates high fat diet-induced metabolic dysfunction-associated fatty liver disease via activation of FXR signaling pathway.","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.176196","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"176196"}}